Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 207
8
Diseases
8
Unique genes
0.289
Avg. similarity score
Pseudoxanthoma elasticum
Most-connected disease (7 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Pseudoxanthoma elasticum
Cole disease
Coronary medial sclerosis of infancy
Crystal arthropathy
arterial calcification, generalized, of infancy, 1
hypopigmentation-punctate palmoplantar keratoderma syndrome
Dubin-johnson syndrome
inherited pseudoxanthoma elasticum
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Pseudoxanthoma elasticum | 7 | 7 | 5 |
| Cole disease | 5 | 5 | 1 |
| Coronary medial sclerosis of infancy | 5 | 5 | 1 |
| Crystal arthropathy | 5 | 5 | 4 |
| arterial calcification, generalized, of infancy, 1 | 5 | 5 | 1 |
| hypopigmentation-punctate palmoplantar keratoderma syndrome | 5 | 5 | 1 |
| Dubin-johnson syndrome | 1 | 1 | 1 |
| inherited pseudoxanthoma elasticum | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ENPP1 | 6 / 8 | arterial calcification, generalized, of infancy, 1, Cole disease, Coronary medial sclerosis of infancy, Crystal arthropathy and 2 more |
| ABCC2 | 2 / 8 | Dubin-johnson syndrome, Pseudoxanthoma elasticum |
| ABCC6 | 2 / 8 | inherited pseudoxanthoma elasticum, Pseudoxanthoma elasticum |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| ABC transporters | KEGG | 3 / 45 | 100× | 2.72e-6 | 1.15e-4 ✓ sig. |
| Heme degradation | Reactome | 2 / 14 | 214× | 3.52e-5 | 9.55e-4 ✓ sig. |
| Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | KEGG | 2 / 21 | 143× | 8.10e-5 | 1.89e-3 ✓ sig. |
| Glycosaminoglycan biosynthesis - heparan sulfate / heparin | KEGG | 2 / 24 | 125× | 1.06e-4 | 2.36e-3 ✓ sig. |
| A tetrasaccharide linker sequence is required for GAG synthesis | Reactome | 2 / 26 | 115× | 1.25e-4 | 2.69e-3 ✓ sig. |
| Antifolate resistance | KEGG | 2 / 30 | 100× | 1.67e-4 | 3.40e-3 ✓ sig. |
| Folate transport and metabolism | KEGG | 2 / 31 | 96.9× | 1.79e-4 | 3.59e-3 ✓ sig. |
| Defective ABCC2 causes Dubin-Johnson syndrome | Reactome | 1 / 1 | 1,501× | 6.66e-4 | 9.96e-3 ✓ sig. |
| Defective ABCC6 causes pseudoxanthoma elasticum (PXE) | Reactome | 1 / 1 | 1,501× | 6.66e-4 | 9.96e-3 ✓ sig. |
| ABC-family proteins mediated transport | Reactome | 2 / 81 | 37.1× | 1.23e-3 | 1.58e-2 ✓ sig. |
| Bile secretion | KEGG | 2 / 90 | 33.4× | 1.51e-3 | 1.86e-2 ✓ sig. |
| Vitamin B2 (riboflavin) metabolism | Reactome | 1 / 7 | 214× | 4.65e-3 | 4.18e-2 ✓ sig. |
| Riboflavin metabolism | KEGG | 1 / 8 | 188× | 5.32e-3 | 4.56e-2 ✓ sig. |
| Vitamin B5 (pantothenate) metabolism | Reactome | 1 / 9 | 167× | 5.98e-3 | 4.92e-2 ✓ sig. |
| Heme biosynthesis | Reactome | 1 / 14 | 107× | 9.29e-3 | 6.56e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| inorganic diphosphate transport | GO:0030505 | 2 / 4 | 1,168× | 9.62e-7 | 8.05e-5 ✓ sig. |
| carboxylic acid transport | GO:0046942 | 2 / 5 | 934× | 1.60e-6 | 1.21e-4 ✓ sig. |
| xenobiotic transport across blood-brain barrier | GO:1990962 | 2 / 6 | 779× | 2.40e-6 | 1.67e-4 ✓ sig. |
| leukotriene transport | GO:0071716 | 2 / 7 | 667× | 3.36e-6 | 2.19e-4 ✓ sig. |
| intracellular phosphate ion homeostasis | GO:0030643 | 2 / 10 | 467× | 7.20e-6 | 4.02e-4 ✓ sig. |
| glycosaminoglycan metabolic process | GO:0030203 | 2 / 12 | 389× | 1.06e-5 | 5.43e-4 ✓ sig. |
| transepithelial transport | GO:0070633 | 2 / 13 | 359× | 1.25e-5 | 6.21e-4 ✓ sig. |
| phosphate ion homeostasis | GO:0055062 | 2 / 15 | 311× | 1.68e-5 | 7.83e-4 ✓ sig. |
| glycosaminoglycan biosynthetic process | GO:0006024 | 2 / 20 | 234× | 3.04e-5 | 1.23e-3 ✓ sig. |
| proteoglycan biosynthetic process | GO:0030166 | 2 / 21 | 222× | 3.35e-5 | 1.33e-3 ✓ sig. |
| glycoprotein biosynthetic process | GO:0009101 | 2 / 21 | 222× | 3.35e-5 | 1.33e-3 ✓ sig. |
| chondroitin sulfate proteoglycan biosynthetic process | GO:0050650 | 2 / 26 | 180× | 5.19e-5 | 1.85e-3 ✓ sig. |
| heparan sulfate proteoglycan biosynthetic process | GO:0015012 | 2 / 30 | 156× | 6.93e-5 | 2.30e-3 ✓ sig. |
| ATP metabolic process | GO:0046034 | 2 / 36 | 130× | 1.00e-4 | 3.03e-3 ✓ sig. |
| monoatomic anion transmembrane transport | GO:0098656 | 2 / 40 | 117× | 1.24e-4 | 3.56e-3 ✓ sig. |